QUERCIS PHARMA
Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases. It is advancing a development pipeline of late-stage clinical studies that focus on the prevention of VTE in cancer patients. In addition, Quercis targets other diseases associated with thrombotic events, such as sickle cell disease (SCD), Ebola, and COVID-19. The Company’s lead drug candidate acts as an antithrombotic with a significantly lower risk of adverse events than existing treatments. The company was founded in 2019 and is based in Zug, Switzerland.
QUERCIS PHARMA
Social Links:
Industry:
Biopharma Biotechnology Life Science Medical Pharmaceutical
Founded:
2019-01-01
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.quercis.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
150 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Apache
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Mikrobiomik
Mikrobiomik is a biopharmaceutical company that provides innovative solutions for chronic diseases.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Oxford Cannabinoid Technologies
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Private Equity Round - Quercis Pharma
Official Site Inspections
http://www.quercis.com Semrush global rank: 9.09 M Semrush visits lastest month: 217
- Host name: 212.243.197.113
- IP address: 212.243.197.113
- Location: Onex Switzerland
- Latitude: 46.1877
- Longitude: 6.0981
- Timezone: Europe/Zurich
- Postal: 1213
More informations about "Quercis Pharma" on Search Engine
Quercis Pharma – FOR A HEALTHIER WORLD
About us. Quercis Pharma AG is a privately owned, biopharmaceutical company based in Zug, Switzerland. Quercis Pharma is advancing a development pipeline of late-stage clinical studies that focus on the prevention of VTE in …See details»
People – Quercis Pharma
Over 25 years of experience in the pharmaceutical and biotech industry. Former Chief Medical Officer at Vifor Pharma. Previous Chief Strategy Officer and President of Global clinical development at WorldWide Clinical Trials. …See details»
Mission – Quercis Pharma
Mission. Quercis is studying the use of its novel, proprietary and orally available anti-thrombotic, anti-cancer, antiviral and immuno-modulatory platforms to deliver innovative, effective, safe and broadly accessible treatments to patients with potentially life-threatening conditions addressing significant unmet medical needs.See details»
Quercis Pharma - Crunchbase Company Profile & Funding
Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases. It is advancing a development pipeline of late-stage clinical studies that focus on the prevention of VTE in cancer patients.See details»
Quercis Pharma AG – Swiss Biotech
Quercis Pharma AG is a private Swiss biotech company advancing a novel antithrombotic in multiple indications: the lead program is prevention of Venous Thrombosis Embolism in advanced cancer patients (phase III) followed by clinical trials in Sickle Cell Disease (phase II) and Covid-19 (phase II).See details»
Quercis Pharma | Top Drug Discovery and Development …
Quercis Pharma stands as a distinctive company boasting some of the world’s most exceptional Cancer and thrombosis specialists. For instance, Dr. Jean-Pierre Bizzari, the Chairman of its Scientific Advisory Board, holds a record of overseeing the registration of …See details»
Quercis Pharma | LinkedIn
Quercis Pharma AG is leveraging its novel antithrombotic platform to deliver safe and innovative treatments to patients with a variety of complex diseases that are poorly addressed by today’s...See details»
Quercis Pharma: Transforming Therapeutic Frontiers
Quercis Pharma, headquartered in Zug, Switzerland, is a privately owned biopharmaceutical company at the forefront of precision medicine and therapeutic innovation.See details»
Org Chart Quercis Pharma - The Official Board
The organizational chart of Quercis Pharma displays its 7 main executives including Thomas LinesSee details»
Quercis Pharma Licenses Key Patents for Thromboembolism …
ZUG, Switzerland, Jan. 25, 2021 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, announced that it has...See details»
Quercis Pharma Secures USD 150 Million Investment Commitment ... - BioSpace
ZUG, Switzerland, Dec. 9, 2021 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announced that it has signed an Agreement with GEM Global Yield LLC SCS ("GEM"), the Luxembourg based private alternative investment group, to provide Quercis with a …See details»
QUERCIS PHARMA LICENSES KEY PATENTS FOR THROMBOEMBOLISM PLATFORM ACROSS ...
Jan 21, 2021 Quercis Pharma AG is a private, biopharmaceutical company based in Zug, Switzerland. Quercis Pharma is advancing a development pipeline of late-stage clinical studies that focus on the prevention of venous thromboembolism (VTE) in cancer patients.See details»
Quercis Pharma Secures $150M Investment Commitment from GEM
Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announced that it has signed an Agreement with GEM Global Yield LLC SCS, the Luxembourg based private alternative investment group, to provide Quercis with a share subscription facility of up to USD 150 million for a 36-mont...See details»
Quercis Pharma - Funding, Financials, Valuation & Investors
Funding. Quercis Pharma has raised a total of. $150M. in funding over 1 round. This was a Private Equity round raised on Dec 9, 2021. Quercis Pharma is funded by The Global Emerging Markets Group. Unlock for free. Funding Rounds. Number of Funding Rounds 1. Total Funding Amount. Unlock for free. Quercis Pharma has raised a total of. $150M.See details»
Quercis Pharma Company Profile 2024: Valuation, Funding
Quercis Pharma Company Profile 2024: Valuation, Funding & Investors | PitchBook. Quercis Pharma Overview. Update this profile. Year Founded. 2019. Status. Private. Employees. 3. Latest Deal Type. Early Stage VC. Latest Deal Amount. $150M. Investors. 2. General Information. Description.See details»
Quercis Pharma AG - The European Life Sciences Web Portal
Jan 1, 2019 Quercis Pharma AG is a private, biopharmaceutical company based in Zug, Switzerland. Quercis Pharma is advancing a development pipeline of late-stage clinical studies that focus on the prevention of venous thromboembolism (VTE) in cancer patients.See details»
Quercis Pharma Secures USD 150 Million Investment Commitment from GEM ...
ZUG, Switzerland, Dec. 9, 2021 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announced that it has...See details»
Our Credo – Core Values – Quercis Pharma
Our Credo - Core Values. The patients who will eventually use our drugs are the most important consideration we have as a company. We are responsible first for their safety and then for making sure our drugs work to improve their health and quality of life while dealing with their medical conditions.See details»
Quercis Pharma - Crunchbase
Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.See details»
Drug development – Quercis Pharma
Drug Development. Product. Isoquercetin patented formulation (Kinisoquin™) Isoquercetin prevents platelet activation and initiation of the thrombotic cascade. Over 20’000 publications referencing Isoquercetin and Quercetin in multiple indications. Safety profile of Kinisoquin™ (our main investigational drug) is well established.See details»